0001851933-21-000001.txt : 20210318 0001851933-21-000001.hdr.sgml : 20210318 20210318105742 ACCESSION NUMBER: 0001851933-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210318 DATE AS OF CHANGE: 20210318 EFFECTIVENESS DATE: 20210318 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VIN-24 Neurexis Therapeutics, LLC CENTRAL INDEX KEY: 0001851933 IRS NUMBER: 862041070 STATE OF INCORPORATION: AR FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-392691 FILM NUMBER: 21753494 BUSINESS ADDRESS: STREET 1: 535 W. RESEARCH CENTER BLVD. STREET 2: SUITE 135 CITY: FAYETTEVILLE STATE: AR ZIP: 72701 BUSINESS PHONE: 4795212592 MAIL ADDRESS: STREET 1: 535 W. RESEARCH CENTER BLVD. STREET 2: SUITE 135 CITY: FAYETTEVILLE STATE: AR ZIP: 72701 D 1 primary_doc.xml X0708 D LIVE 0001851933 VIN-24 Neurexis Therapeutics, LLC 535 W. RESEARCH CENTER BLVD. SUITE 135 FAYETTEVILLE AR ARKANSAS 72701 4795212592 ARKANSAS None None Limited Liability Company true 2021 Robert Calvin Goforth 535 W. Research Center Blvd. Suite 135 Fayetteville AR ARKANSAS 72701 Executive Officer Director CEO of Manager. Other Decline to Disclose 06b false 2021-03-09 false true false 5000 None None None None N/A N/A Fayetteville AR ARKANSAS 72701 AR ARKANSAS TX TEXAS false 500000 50000 450000 false 7 0 0 0 false VIN-24 Neurexis Therapeutics, LLC Robert Calvin Goforth Robert Calvin Goforth CEO of Manager 2021-03-18